INSIGHTS ON DRUG DEVELOPMENT
-
Expanding Translational Research Concepts With Genedata Profiler
The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.
-
KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging
Simulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.
-
Navigating Challenges During Formulation Development
Gain valuable knowledge on addressing formulation stability, improving product shelf life, and enhancing overall product performance in biopharmaceutical studies.
-
Aggregate Analysis Of Tirzepatide
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Leveraging Innovative Analytics To Ensure The Thermal Stability Of mAb Drug Products9/23/2024
Uncover how innovative Rapid Screening-Differential Scanning Calorimeter technology is enabling robust analysis and regulatory compliance by ensuring the thermal stability of antibody drug products.
-
Validation Provider Shortens The Path To Equipment Qualification8/19/2025
Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.
-
Application Of LC-UV/MS Workflows To Increase Efficiency7/29/2025
Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.
-
A Simple Method For Cell Growth Media Preparation11/3/2025
Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.
-
Native SEC-MALS Characterization Using A Chromatography Data System5/7/2026
Native SEC‑MALS offers a calibration‑free way to accurately characterize peptide oligomers, helping scientists distinguish true higher‑order structures while avoiding bias.
DRUG DEVELOPMENT SOLUTIONS
-
Explore a wide variety of DHR temperature systems and accessories, designed for superior performance and ease-of-use.
-
Boost genomics productivity with a solution built for speed, precision, and high throughput with extended walkaway times and reliable performance that helps teams get more done.
-
Advanced nanotechnology improves biologics with higher drug loads, better stability, new delivery routes, and enhanced performance in injectables, inhalation, and long‑acting therapies.
-
Curia’s DMPK scientists deliver expert solutions for your drug discovery programs. Providing bioanalytical methods development, in vitro ADMET testing and in vivo PK and PD services that span all stages of drug discovery up to candidate selection.
-
Allow you students to gain practical hands-on experience exploring the following fundamentals of mass spectrometry: